See If Peptide Therapy Is Right for You Take our quick quiz to discover which peptide therapy may best support your health, recovery, and longevity goals
Retatrutide owns the incretin and glucagon territory, driving both reduced intake and increased burn
Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, et al
It missed its main target too, but a post hoc slice of the data, the patients taking fosgonimeton on its own without a standard Alzheimers drug alongside it, showed a striking signal on a brain-wave measure called P300 latency, a marker of processing speed, that moved 28 milliseconds in the right direction, along with a hint on a cognitive scale (ACT-AD topline, June 2022)